Rituximab monotherapy for patients with recurrent primary CNS lymphoma

Neurology. 2011 Mar 8;76(10):929-30. doi: 10.1212/WNL.0b013e31820f2d94.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Central Nervous System Neoplasms / drug therapy*
  • Female
  • Humans
  • Karnofsky Performance Status
  • Lymphoma / drug therapy*
  • Male
  • Mental Status Schedule
  • Middle Aged
  • Odds Ratio
  • Pilot Projects
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab